1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. Massachusetts >
  6. Warburg Pincus Invests In Constitution Medical Investors

Investment Summary

Warburg Pincus Invests In Constitution Medical Investors

On June 23, 2008, private equity firm Warburg Pincus invested in healthcare services company Constitution Medical Investors

Investment Highlights
  • This is Warburg Pincus’ 6th transaction in the Healthcare Services sector.
  • This is Warburg Pincus’ 79th transaction in the United States.
  • This is Warburg Pincus’ 5th transaction in Massachusetts.
Investment Fate
  • Constitution Medical Investors was sold to a publicly-traded strategic buyer in 2013 for 220M USD.

Investment Summary
Date 2008-06-23
Target Constitution Medical Investors
Sector Healthcare Services
Investor(s) Warburg Pincus
Deal Type Growth Capital

Target

Constitution Medical Investors

Boston, Massachusetts, United States
Constitution Medical Investors, Inc. (CMI) is the developer of a highly innovative hematology testing system, which is designed to provide faster and more accurate diagnosis of blood-related diseases, thereby improving patient care.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 136 of 485
Sector (Healthcare Services) 6 of 20
Type (Growth Capital) 27 of 159
State (Massachusetts) 5 of 10
Country (United States) 79 of 238
Year (2008) 10 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-18 GANIC Pharmaceuticals

Bridgewater, New Jersey, United States

GANIC Pharmaceuticals Inc. is a specialty pharmaceutical company founded by Warburg Pincus together with a highly seasoned group of senior executives with 65 years of collective experience in the pharmaceutical industry. The company's founders include Chief Executive Officer Paul Edick, Chief Financial Officer Corey Fishman, and Chief Commercial Officer Chris Maltese, all formerly senior executives at MedPointe Pharmaceuticals.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-01 Turnitin

Oakland, California, United States

Turnitin is a provider of academic integrity and writing solutions and supports authentic work across the curriculum. Turnitin provides instructors with the tools to prevent plagiarism, engage students in the writing process, and provide personalized feedback. Turnitin was founded in 1997 and is based in Oakland, California.

Buy -
Mergr

Product

Company

Legal